The CHMP also backed approval of Pfizer’s antibiotic infusion Emblaveo (aztreonam-avibactam) to treat complicated intra-abdominal infection (cIAI) and complicated urinary tract infection (cUTI ...

While most pharma companies have exited the antibiotics area, Japanese drugmaker Shionogi has stuck with it and has just expanded its pipeline with a deal to buy US biotech Qpex Biopharma.

New treatments for Prader-Willi Syndrome and hemophilia; FDA fast tracks a chlamydia vaccine candidate; over-the-counter test cleared for identifying chlamydia, gonorrhea and trichomoniasis.